THE RELEVANCE OF THE DIAGNOSIS OF INFECTIOUS DISEASES AND THE INTERPRETATION OF MEASURES TO IMPROVE DIAGNOSIS

Article Sidebar

PDF
Issue: Vol. 5 No. 11 : Eurasian Journal of Medical and Natural Sciences
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

Head of the Department of Microbiology, Virology and Immunology, Professor, DcS, Tashkent State Medical University, Tashkent, Uzbekistan.
voyna_microbam@mail.ru
Assistant at the Department of Microbiology, virology and immunology of Tashkent State Medical University, Tashkent, Uzbekistan
dilafruzgulmurotova82@gmail.com
Student of Tashkent State Medical University, 1st Faculty of General Medicine, Group 217A, Tashkent, Uzbekistan
norqulovashaxzoda199@gmail.com
Student of Tashkent State Medical University, 2nd Faculty of General Medicine, Group 214A, Tashkent, Uzbekistan
sabrfaqatsabr07@gmail.com

Abstract:

The economy and human civilization are greatly impacted by infectious illnesses, which pose serious threats to world health.  Functional probes have shown tremendous promise in recent years as essential biological media for infectious disease research and treatment.  Pathogen identification, biological mechanism investigation, and anti-infective medication development are some of their uses in the field of infectious illnesses. An overview of the pathophysiology, classification, and severity of infectious diseases is given in this review.  Using common examples, we then looked at the unique features and design approaches of functional probes for infectious illness diagnosis and treatment, providing insight into their logic.  We go over the present situation and difficulties surrounding the therapeutic application of functional probes.  We also looked into the potential use of these probes in the detection and management of infectious disorders. 

Keywords:

Article Details

How to Cite:

Nuruzova, Z., Gulmurotova, D., Norqulova, S. ., & Omonova, M. . (2025). THE RELEVANCE OF THE DIAGNOSIS OF INFECTIOUS DISEASES AND THE INTERPRETATION OF MEASURES TO IMPROVE DIAGNOSIS. Eurasian Journal of Medical and Natural Sciences, 5(11), 97–106. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/65534

References:

R. E. Baker, A. S. Mahmud, I. F. Miller, M. Rajeev, F. Rasambainarivo, B. L. Rice, S. Takahashi, A. J. Tatem, C. E. Wagner, L.-F. Wang, A. Wesolowski, C. J. E. Metcalf, Nat. Rev. Microbiol. 2021, 20, 193.

Schmidt TE, Vieceli T, Damasceno LS, Kimuda S, Pasqualotto AC, Bahr NC. Evolving Epidemiology, Improving Diagnostic Tests and Their Importance for the Correct Diagnosis of Histoplasmosis. Journal of Fungi. 2025; 11(3):196. https://doi.org/10.3390/jof11030196

https://www.idsociety.org/practice-guideline/laboratory-diagnosis-of-infectious-diseases/ Skjøt-Arkil H, Heltborg A, Lorentzen MH, et alImproved diagnostics of infectious diseases in emergency departments: a protocol of a multifaceted multicentre diagnostic studyBMJ Open 2021;11:e049606. doi: 10.1136/bmjopen-2021-049606

J Michael Miller, Matthew J Binnicker, Sheldon Campbell, et al., A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology, Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages e1–e94, https://doi.org/10.1093/cid/ciy381

Alsharksi AN, Sirekbasan S, Gürkök-Tan T, Mustapha A. From Tradition to Innovation: Diverse Molecular Techniques in the Fight Against Infectious Diseases. Diagnostics. 2024; 14(24):2876. https://doi.org/10.3390/diagnostics14242876

Kadja, T.; Liu, C.; Sun, Y.; Chodavarapu, V.P. Low-Cost, Real-Time Polymerase Chain Reaction System for Point-of-Care Medical Diagnosis. Sensors 2022, 22, 2320.

Kostyusheva, A.; Brezgin, S.; Babin, Y.; Vasilyeva, I.; Glebe, D.; Kostyushev, D.; Chulanov, V. CRISPR-Cas systems for diagnosing infectious diseases. Methods 2022, 203, 431–446.

Lamb, L.E.; Bartolone, S.N.; Ward, E.; Chancellor, M.B. Rapid detection of novel coronavirus (COVID-19) by reverse transcription-loop-mediated isothermal amplification. PLoS ONE 2020, 15, e0234682.

Corman, V.M.; Landt, O.; Kaiser, M.; Molenkamp, R.; Meijer, A.; Chu, D.K.; Bleicker, T.; Brünink, S.; Schneider, J.; Schmidt, M.L.; et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020, 25, 2000045.

Dramé, M.; Tabue Teguo, M.; Proye, E.; Hequet, F.; Hentzien, M.; Kanagaratnam, L.; Godaert, L. Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? J. Med. Virol. 2020, 92, 2312–2313.

Binnie, A.; Fernandes, E.; Almeida-Lousada, H.; de Mello, R.A.; Castelo-Branco, P. CRISPR-based strategies in infectious disease diagnosis and therapy. Infection 2021, 49, 377–385.

Sebastião, C.S.; Pingarilho, M.; Bathy, J.; Bonfim, E.; Toancha, K.; Miranda, M.N.S.; Martins, M.R.O.; Gomes, P.; Lázaro, L.; Pina-Araujo, I.; et al. MARVEL-minimising the emergence and dissemination of HIV-1 drug resistance in Portuguese-speaking African Countries (PALOP): Low-cost portable NGS platform for HIV-1 surveillance in Africa. BMC Infect. Dis. 2024, 24, 884.

Schmitz, J.E.; Stratton, C.W.; Persing, D.H.; Tang, Y.W. Forty Years of Molecular Diagnostics for Infectious Diseases. J. Clin. Microbiol. 2022, 60, e0244621.

Schoonbroodt, S.; Ichanté, J.L.; Boffé, S.; Devos, N.; Devaster, J.M.; Taddei, L.; Rondini, S.; Arora, A.K.; Pascal, T.; Malvaux, L. Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America. Front. Microbiol. 2023, 13, 1098133.

Ahmadzadeh, M.; Vahidi, H.; Mahboubi, A.; Hajifathaliha, F.; Nematollahi, L.; Mohit, E. Different Respiratory Samples for COVID-19 Detection by Standard and Direct Quantitative RT-PCR: A Literature Review. Iran J. Pharm. Res. 2021, 20, 285–299.

Freitas, V.L.T.; Novaes, C.T.G.; Sartori, A.M.C.; Carvalho, N.B.; Silva, S.C.V.D.; Nakanishi, É.S.; Salvador, F.; Castro, C.N.; Bezerra, R.C.; Westphalen, E.V.N.; et al. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. PLoS Negl. Trop. Dis. 2024, 18, e0011961.

Freitas, V.L.T.; Novaes, C.T.G.; Sartori, A.M.C.; Carvalho, N.B.; Silva, S.C.V.D.; Nakanishi, É.S.; Salvador, F.; Castro, C.N.; Bezerra, R.C.; Westphalen, E.V.N.; et al. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. PLoS Negl. Trop. Dis. 2024, 18, e0011961.

Sule, W.F.; Oluwayelu, D.O. Real-time RT-PCR for COVID-19 diagnosis: Challenges and prospects. Pan Afr. Med. J. 2020, 35, 121.

van Kasteren, P.B.; van der Veer, B.; van den Brink, S.; Wijsman, L.; de Jonge, J.; van den Brandt, A.; Molenkamp, R.; Reusken, C.B.E.M.; Meijer, A. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J. Clin. Virol. 2020, 128, 104412.

Kay, A.; Vasiliu, A.; Carratala-Castro, L.; Mtafya, B.; Mendez Reyes, J.E.; Maphalala, N.; Munguambe, S.; Mulengwa, D.; Ness, T.; Saavedra, B.; et al. Stool4TB Global Partnership. Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: A multinational, prospective diagnostic accuracy study. Lancet Microbe 2024, 5, e433–e441.